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TheNAD-synthesising enzymeNmnat2 is a critical survival factor for axons in vitro and in vivo.We recently
reported that loss of axonal transport vesicle association throughmutations in its isoform-specific targeting
and interaction domain (ISTID) reduces Nmnat2 ubiquitination, prolongs its half-life and boosts its axon
protective capacity in primary culture neurons. Here, we report evidence for a role of ISTID sequences in
tuning Nmnat2 localisation, stability and protective capacity in vivo. Deletion of central ISTID sequences
abolishes vesicle association and increases protein stability of fluorescently tagged, transgenic Nmnat2 in
mouse peripheral axons in vivo. Overexpression of fluorescently tagged Nmnat2 significantly delays
Wallerian degeneration in these mice. Furthermore, while mammalian Nmnat2 is unable to protect
transected Drosophila olfactory receptor neuron axons in vivo, mutant Nmnat2s lacking ISTID regions
substantially delay Wallerian degeneration. Together, our results establish Nmnat2 localisation and
turnover as a valuable target for modulating axon degeneration in vivo.
T
he NAD-synthesising enzyme Nmnat2 is a critical, endogenous survival factor for axons. Specific depletion
of Nmnat2 in primary culture axons induces spontaneous degeneration that is rescued by expression of
WldS, suggesting a constant supply of Nmnat2 from the cell body into axons is required to ensure axon
survival1. Similarly, peripheral nerve defects and neonatal mortality in Nmnat2 gene-trap mice are rescued by
homozygous expression of WldS, strongly suggesting a role for Nmnat2 in axon maintenance in vivo2. Due to its
very short half-life, levels of Nmnat2 distal to an injury decline rapidly, prior to fast Wallerian degeneration1.
Similarly, depletion of axonal Nmnat2 distal to an obstruction could account for degeneration when axonal
transport is blocked. Delayed Wallerian degeneration, as achieved by expression of the WldS protein3 or by
axonally targeted Nmnat14,5, is the result, at least in part, of a much longer half-life of these Nmnat isoforms
compared to Nmnat2, meaning that they can substitute the critical NAD-synthetic enzyme activity to keep axons
alive despite the decline in levels of Nmnat21. However, due to the requirement for ectopic expression of an
introduced protein, the clinical usefulness of re-targeted forms of Nmnat1 (such as WldS) is limited. In contrast,
modulation of the turnover, enzymatic activity or delivery of the endogenous survival factor, Nmnat2, is a much
more promising avenue to address axon degeneration during ageing and in disease. Further supporting a pro-
survival function of Nmnat2 are its reported protective effects against injury-induced degeneration in live
zebrafish6 andmouse primary culture axons1,7 as well as against neurodegeneration in a tauopathymousemodel8.
Nmnat2 is extremely labile, undergoes K48 poly-ubiquitination9 and its turnover is at least partially mediated
by the ubiquitin proteasome system1. Accordingly, inhibition of the ubiquitin proteasome system delays the onset
ofWallerian degeneration in cut primary culture axons10, potentially by stabilising Nmnat2 levels. Additionally, a
recent study reported Drosophila Nmnat (dNmnat) as a potential downstream target of the E3 ubiquitin ligase
Highwire. In the absence of Highwire, dNmnat as well as transgenic mouse Nmnat2 are stabilised, resulting in
significant protection of injured axons11. Furthermore, there is recent evidence showing that the mammalian
homologue ofHighwire, PhrI, regulates turnover of Nmnat2 inmammalian axons. Loss of PhrI leads to increased
levels of virally-transduced Nmnat2 and delays axon degeneration after injury inmouse peripheral axons12. Thus,
modulation of Nmnat2 turnover presents a potentially promising target for delaying axon degeneration.
We recently reported that Nmnat2 is transported into primary culture axons by means of a Golgi-derived
axonal transport vesicle population with which it associates through palmitoylation of a double-cysteine motif.
This palmitoylation site is located in the exon 6-encoded region of Nmnat2, at the centre of the isoform-specific
targeting and interaction domain (ISTID)13. Interestingly, however, we found that dissociation from transport
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vesicles through loss or mutation of the central, exon 6-encoded
ISTID region enhances the ability of overexpressed Nmnat2 to pre-
serve primary culture neurites after axotomy. This increased protect-
ive capacity was at least in part due to reduced levels of ubiquitination
and an increased half-life of mutant, cytosolic Nmnat2 variants,
suggestingmodulation of Nmnat2 subcellular localisation as ameans
to enhance Nmnat2 half-life and protective capacity9.
The Wallerian degeneration phenotype after overexpression in
primary culture has not always translated into efficacy in vivo14–16,
andWallerian degeneration inmouse sciatic nerve takes around four
times longer than for injured neurites in primary culture15,17. Thus it
is important to confirm some of our key primary culture findings in
vivo. Here we report evidence for a role for ISTID regions in tuning
Nmnat2 localisation, turnover and protective capacity in transgenic
mice and Drosophila in vivo. Using mice expressing wild-type
Nmnat2 tagged with a modified yellow fluorescent protein
(Nmnat2-Venus) or mutant Nmnat2Dex6-Venus, we find that loss
of its central ISTID region leads to a diffuse, non-vesicular localisa-
tion of Nmnat2 in peripheral nerves. Confirming our previous obser-
vations, we also find evidence for an increased half-life of
Nmnat2Dex6-Venus compared to Nmnat2-Venus, suggesting, as
the two are closely linked in primary culture9, a role for Nmnat2
subcellular localisation in modulating its turnover in vivo.
Additionally, we confirm that overexpression of a stabilised form
of Nmnat2 delays Wallerian degeneration in mouse peripheral
nerves. Finally, we show that, while wild-type Nmnat2 fails to protect
Drosophila olfactory axons, deletion of ISTID regions, transforms
Nmnat2 into a highly protective molecule for Drosophila axons in
vivo. These findings suggest modulation of the subcellular localisa-
tion of Nmnat2 as a novelmeans of extending axon survival in ageing
and disease.
Results
Expression of Nmnat2-Venus and Nmnat2Dex6-Venus in trans-
genic mice. In order to study the role of exon 6 – encoded se-
quences (which we refer to as the ‘‘central ISTID region’’) in
regulating Nmnat2 localisation and turnover in vivo, we generated
two strains of transgenic mice. Nmnat2-Venus mice (lines 1, 2 and 3
used in this study) express full-length, wild-type Nmnat2 fused to
YFP Venus while Nmnat2Dex6-Venus mice express Nmnat2 defi-
cient of exon 6-encoded central ISTID sequences (see Supplementary
Figure 1 for an outline of relevantNmnat2 regions and the position of
the exon 6 deletion). Expression in both strains is driven by the
Thy1.2 neuron-specific promoter18. The presence of the transgene
was confirmed by PCR from genomic DNA (Supplementary Figure
2a) and expression of the fusion protein was detectable by Western
Blot in total brain as well as in sciatic nerve (Supplementary Figure
2b). Total expression levels in sciatic nerve vary between lines, with
line 1 in particular showing notably higher total expression levels
than the other Nmnat2-Venus lines, and than Nmnat2Dex6-Venus
mice. However, in interpreting this observation, one has to consider
the reported finding that Thy1.2-driven transgene expression does
not necessarily occur in all neurons and that expression patterns vary
widely between lines18–20. For this reason, we quantified the per-
centage of axons expressing the transgene in sciatic nerves from all
lines. Cryo-sections of sciatic nerves were stained with FluoroMyelin
Red dye and the number of axons exhibiting detectable above-
background levels of YFP fluorescence quantified as a percentage
of total axons (identified by myelin staining, see Methods for
details). As expected, we found considerable differences between
lines (Figure 1). In particular, Nmnat2-Venus line 2 showed detec-
table expression in virtually all axons while expression in other lines
was detectable in around 20–50% of axons. Figure 1a also illustrates
that expression levels (as judged by YFP intensity) vary between
individual axons within the same nerve. Thus we cannot rule out
the possibility that some axons might express very low levels of the
transgene below our detection threshold. The transgene was
inherited with the expected ratios in all transgenic lines and no
overt phenotypic abnormalities were observed up to at least 12
months of age, suggesting that expression of Nmnat2-Venus or
Nmnat2Dex6-Venus does not have obvious adverse effects.
The central ISTID region is necessary for vesicle association in
vivo. In primary culture neurons, Nmnat2 associates with Golgi-
derived transport vesicles and undergoes fast axonal transport.
Loss of the palmitoylation site in its central ISTID region is suffi-
cient to disrupt transport vesicle association and causes Nmnat2 to
assume a diffuse, cytosolic distribution9. In order to test whether
Nmnat2 assumes a vesicular localisation in vivo, and whether the
central ISTID region is necessary for this, we analysed whole-mount
sciatic nerves of Nmnat2-Venus and Nmnat2Dex6-Venus mice. As
shown in Figure 2a, clearly identifiable vesicles were observed in
sciatic nerve axons from all Nmnat2-Venus lines. In contrast, only
diffuse, cytosolic staining was observed in Nmnat2Dex6-Venus
axons with no evidence of vesicular association in any of the axons
analyzed. Additionally, we confirmed that Nmnat2-Venus vesicles
were mobile in peripheral axons through live-imaging of sciatic
nerve explants. We observed abundant, bidirectional movement of
vesicles in Nmnat2-Venus axons. In contrast, no vesicular struc-
tures or movement were observed in Nmnat2Dex6-Venus axons
(Figure 2b and Supplementary Movie 1). These results are consis-
tent with a vesicular localisation of Nmnat2-Venus in vivo that is
dependent on the central ISTID region.
Loss of the central ISTID region prolongs Nmnat2 half-life in
vivo. We previously described emetine chase experiments in HEK
293 cells showing that loss of exon 6-encoded sequences prolonged
Nmnat2 half-life considerably9. Due to the low level of expression of
endogenous Nmnat2 in axons, the limited quality of available
antibodies12 and the potentially compounding issue of expression
in non-neuronal cells, the in vivo turnover of endogenous Nmnat2
in axons is difficult to study. We therefore used the neuron-specific
expression of Nmnat2-Venus in our transgenic mice to test whether
loss of the central ISTID region delays Nmnat2 turnover in mouse
peripheral nerves. For this, we performed unilateral sciatic nerve
lesions and collected sciatic nerves 24 or 72 hours after injury (as
shown in Figure 4 and discussed below,Wallerian degeneration does
not occur at these time points in axons expressing the transgene in
Nmnat2-Venus or Nmnat2Dex6-Venus mice). For quantification,
we normalised Nmnat2-Venus levels to bIII-Tubulin levels. For
Nmnat2-Venus, the relative level was unchanged 24 hours after
cut, but we observed a substantial drop at 72 hours after cut
(Figure 3a, c). In contrast, there was essentially no change in
Nmnat2Dex6-Venus levels relative to bIII-Tubulin at 72 hours
after cut (Figure 3b, c). This suggests that loss of the central ISTID
region stabilises Nmnat2-Venus in vivo. It is important to note,
however, that the observed rate of turnover for wild-type Nmnat2-
Venus is considerably slower than that reported for endogenous
Nmnat2 in primary culture neurites1, as well as for FLAG-tagged
Nmnat2 in HEK 293 cells9. This is most likely attributable to the
YFP tag in the transgenic mice as we found Nmnat2-EGFP to be
considerably more stable than FLAG-Nmnat2 in HEK 293 cells
(Supplementary Figure 3). Thus, whilst the rate of turnover we ob-
served for Nmnat2-Venus probably does not reflect the true half-life
of untagged, wild-type Nmnat2, the fact that Nmnat2Dex6-Venus is
considerably more stable than Nmnat2-Venus in cut sciatic nerve
nevertheless strongly supports a role for the central ISTID region in
tuning Nmnat2 turnover in vivo.
Overexpressed, stabilised Nmnat2 delays Wallerian degeneration
in vivo. We next reasoned that the relative overexpression of
Nmnat2-Venus, together with its likely stabilisation compared to
wild-type Nmnat2, should delay the course of Wallerian degeneration
www.nature.com/scientificreports
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Figure 1 | Characterisation of transgene expression in Nmnat2-Venus and Nmnat2Dex6-Venus mouse lines. (a) Cryostat cross-sections (20 mm
thickness) of sciatic nerves of Nmnat2-Venus and Nmnat2Dex6-Venus mice. YFP fluorescence from transgene expression is shown in green and
FluoroMyelin staining is shown in red. In close-up images, white arrows indicate axons that were scored negative for transgene expression and white
asterisks indicate axons that were scored positive (note that in line 2 images, virtually no axons were found to be negative for transgene expression).
(b) Quantification of the percentage of total axons (identified by FluoroMyelin staining) that showed detectable (above-background) YFP expression in
Nmnat2-Venus and Nmnat2Dex6-Venus mouse sciatic nerves (see Methods). Error bars indicate SEM.
www.nature.com/scientificreports
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in Nmnat2-Venus transgenic mice. Using sciatic nerve lesion
experiments, we quantified the percentage of axons that appeared
morphologically intact 14 days after injury. In wild-type animals,
degeneration starts at 36 hours after cut and is mostly complete by
72 hours17. Accordingly, 14 days after cut, axons expressing YFP only
(from YFP-H animals) were completely degenerated (Figure 4a, b).
In contrast, Nmnat2-Venus animals showed a significant portion of
intact axons at this time point. The degree of protection varied
between lines, with the largest percentage of intact axons observed
in line 2, but all lines analyzed showed a considerable degree of
protection (Figure 4a, b). The difference in protective capacity
between lines most likely reflects the difference in expression
pattern (see Figure 1) as we observed a very strong correlation
between the percentage of YFP-positive axons and the percentage
of axons protected at 14 days after cut (R2 5 0.9839, Figure 4c).
These results indicate that overexpression of the relatively stable
Nmnat2-Venus fusion protein in peripheral axons is sufficient to
afford a significant delay in the time course of Wallerian
degeneration. In previously described in vitro experiments we
found that loss of exon 6-encoded sequences dramatically
enhanced the ability of Nmnat2 to delay neurite degeneration after
cut when expressed at low levels in primary culture neurons9. In
order to test whether loss of this central ISTID region would also
increase the protective capacity of Nmnat2 in vivo, we compared the
ability of Nmnat2Dex6-Venus to delay axon degeneration after
sciatic nerve injury in mice to that of Nmnat2-Venus. As for the
Nmnat2-Venus lines above, we found substantial protection of
Nmnat2Dex6-Venus axons at 14 days after sciatic nerve injury
(Figure 4a, b), especially when taking into account the percentage
of labelled axons observed (Figures 1 and 4c). As illustrated in
Figure 4c, in wild-type Nmnat2-Venus mice, the fraction of axons
that express detectable levels of Nmnat2-Venus and the fraction of
axons that were morphologically intact 14 days after cut are nearly
identical. This suggests very strong protection by wild-type Nmnat2
when stabilised by fusion to YFP Venus. Thus, there was virtually no
scope for Nmnat2Dex6-Venus to provide stronger protection than
Figure 2 | The central ISTID region is necessary for vesicle association of Nmnat2-Venus in vivo. (a) Single longitudinal confocal slices of whole-
mounted sciatic nerve axons showing numerous clearly identifiable vesicles in nerves from Nmnat2-Venus mice (some highlighted by arrows in each
image) compared to exclusively diffuse, cytosolic staining in nerves from Nmnat2Dex6-Venus mice. Two representative images are shown for each line.
(b) First frame and corresponding kymograph (time-distance graph) of representative sciatic nerve axon live imaging time series from Nmnat2-Venus
and Nmnat2Dex6-Venus mice. Total time represented in kymograph is 2 minutes (240 frames at 2 fps).
www.nature.com/scientificreports
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wild-type Nmnat2-Venus in this case. Accordingly, we observed a
similar maximal protective capacity of Nmnat2Dex6-Venus
compared to wild-type Nmnat2-Venus (Figure 4).This means that
the existing Nmnat2-Venus and Nmnat2Dex6-Venus mouse lines
did not allow us to adequately test the hypothesis that loss of the
central ISTID region boosts the axon protective capacity of Nmnat2
in vivo.
Loss of ISTID regions enhances protective capacity of Nmnat2 in
Drosophila axons. In order to clarify whether loss of central ISTID
regions can improve axon protection by Nmnat2 in vivo, we tested
the protective capacities of wild-type and mutant Nmnat2 isoforms,
lacking any tags that could stabilise the protein, inDrosophila axons.
We previously found that a series of deletion mutants (Nmnat2D32,
D43,D69 andD82 – see Supplementary Figure 1 for an outline of the
location of the deletion in each mutant) based on human Nmnat221
have greatly increased axon protective capacity compared to wild-
type Nmnat2 in mouse primary culture neurites9. The deletions in
thesemutants span parts of the central isoform-specific targeting and
interaction domain (ISTID)13 region of Nmnat2 and include part
(D32) or all of the exon 6 – encoded region (D43, D69 and D82),
which is essential for targeting Nmnat2 to vesicles9. We expressed
wild-type and each of these mutant Nmnat2 isoforms in flies in
which a subset of antennal olfactory receptor neuron (ORN)
axons were labelled by GFP expression (OR22a-Gal4, UAS-
mCD8::GFP)22,23. Axotomy was induced by bilateral third antennal
segment ablation and the number of remaining GFP-positive axons
was scored 7, 14 and 30 days after axotomy. We previously found
non-stabilised wild-type Nmnat2 to be only weakly protective and to
require strong overexpression in order to achieve moderate
protection in mouse primary culture neurites1,9. Consistent with
this and with other previous work24, we found that expression of
untagged human Nmnat2 in Drosophila did not preserve ORN
axons at any of the time points analysed (Figure 5). In contrast,
flies expressing the deletion mutants showed strong preservation of
ablated axons 7 and 14 days after axotomy, with a substantial
proportion being protected until 30 days after antennal ablation
(Figure 5). These findings support a role for the central ISTID
region in modulating Nmnat2 axon protective capacity in vivo.
Moreover, these data also suggest that the molecular mechanisms
by which loss of the central ISTID region boosts Nmnat2 axon
protective capacity are conserved from Drosophila to mammals.
Discussion
Wepreviously reported that loss of exon 6-encoded sequences boosts
the protein stability and axon protective capacity ofNmnat2 in vitro9.
The results presented here confirm that a similar mechanism oper-
ates in vivo. We find that deletion of the central, exon 6-encoded
ISTID region causes loss of vesicle association and delays the turn-
over of Nmnat2-Venus in mouse peripheral axons. Moreover,
untagged mammalian Nmnat2, which is not protective in Droso-
phila ORN axons24 and provided only weak, transient protection in
Drosophila wing axons25, can be transformed into a highly protective
protein for Drosophila axons through deletions of its central ISTID
region. These findings are an important confirmation illustrating the
possibility of turning endogenous Nmnat2 into a highly protective
molecule to address axon degeneration in a mammalian system.
The strong protective effect observed with Nmnat2-Venus alone
meant that our mouse lines did not allow us to directly compare the
protective capacities of wild-type and central ISTID – deficient
Figure 3 | Loss of the central ISTID region stabilises Nmnat2-Venus in vivo. (a) Representative Western Blots (cropped) of Nmnat2-Venus expression
in sciatic nerves fromNmnat2-Venus line 2 animals 24 or 72 hours after axotomy compared to contralateral, uncut nerve from the same animal. Nmnat2-
Venus was detected by the YFP tag. bIII-Tubulin was used as loading control. (b) Representative Western Blot (cropped) of Nmnat2Dex6-Venus
expression (detected by YFP tag) in sciatic nerve 72 hours after axotomy compared to contralateral, uncut nerve from the same animal. bIII-Tubulin was
used as loading control. (c) Quantification of Nmnat2-Venus and Nmnat2Dex6-Venus turnover in cut sciatic nerve. Expression of Nmnat2-Venus (or
Nmnat2Dex6-Venus) was normalised to bIII-Tubulin levels in the same nerve. For presentation purposes, expression levels at 24 and 72 hours after
axotomy were normalised to uncut nerve. Error bars indicate SEM. *** indicates statistically significant difference compared to Nmnat2-Venus
(p , 0.001, n 5 3–4 nerves per line).
www.nature.com/scientificreports
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Nmnat2 in vivo. While it is possible that loss of the central ISTID
region does not improve Nmnat2 – mediated axon protection in
mouse peripheral axons, it appears more likely that the strong over-
expression and enhanced stability of Nmnat2-Venus relative to
endogenous Nmnat2 masks any potential benefit of the deletion of
the central ISTID. Due to the high steady-state level and longer half-
life relative to endogenous Nmnat2, levels of Nmnat2-Venus remain
above the threshold required for axon maintenance, even when its
relative levels drop between 24 and 72 hours after cut. This inter-
pretation is further supported by the observed effect of deletion of the
central ISTID region on the stability of Nmnat2-Venus, which would
likely translate into a higher protective capacity under conditions of
lower expression. Finally, the strong increase in protective capacity of
mammalianNmnat2 ISTID deletionmutants inDrosophila olfactory
receptor neuron axons further supports a role for the central ISTID
region in tuning Nmnat2-mediated axon protection.
Even though Drosophila has only a single Nmnat isoform, our
results suggest that the ISTID–dependent destabilisation or misloca-
lisation mechanism observed for mammalian Nmnat2 is conserved
across species. Mammalian Nmnat2 was previously shown to be able
to substitute for dNmnat to some extent in Drosophila25. Addi-
tionally, Highwire, an E3 ubiquitin ligase proposed to regulate turn-
over and protective capacity of dNmnat, also affects the stability of
mammalian Nmnat2 in Drosophila axons11. Here we find that pro-
tection ofDrosophilaORN axons by mammalian Nmnat2 is boosted
by loss of central ISTID regions, which stabilises Nmnat2 in mam-
malian nerves and greatly enhances axon protection in mammalian
primary culture neurons. These results indicate that the mechanisms
that mediate the delayed degeneration resulting from deletion of
Nmnat2 central ISTID sequences in mammalian primary culture
axons are conserved in Drosophila.
Confirming our primary culture observations, loss of the central
ISTID region does not interfere with the entry ofNmnat2-Venus into
long peripheral axons. While we cannot completely exclude the pos-
sibility that the YFP tag somehow mediates axon entry, this suggests
that long-range vesicle-mediated transport might not be necessary to
deliver Nmnat2 into axons, even in vivo. Other soluble proteins have
been reported to be trafficked into axons by transient attachment to
Figure 4 | Strong axon protection by Nmnat2-Venus and Nmnat2Dex6-Venus after sciatic nerve axotomy. (a) Representative images of
Richardson stained semi-thin (500 nm) sections of 14-day cut or uncut sciatic nerves of YFP-H, Nmnat2-Venus and Nmnat2Dex6-Venus mice.
(b) Quantification of percentage intact axons in uncut and 14-day cut sciatic nerves from YFP-H (YFP), Nmnat2-Venus (line 1, 2 and 3) and
Nmnat2Dex6-Venus (Dex6) mice. Error bars indicate SEM. (c) Graph showing correlation between percentage of axons identified as labelled in sciatic
nerve cryo-sections and percentage of axons preserved in sciatic nerves of the same animals 14 days post-axotomy. Line represents best-fit linear
regression, error bars show SEM. The relevant transgenic line is indicated for each data point.
www.nature.com/scientificreports
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the transport machinery26. This of course raises the question as to the
functional role of Nmnat2 vesicle association in axons. One possibil-
ity, consistent with our results, is that vesicle-association helps to
ensure rapid removal and turnover of Nmnat2. However, given the
absence of adverse effects observed in any of our transgenic lines
overexpressing a stabilised, mislocalised form of the protein, the
importance of Nmnat2 instability to the normal functioning of axons
is presently unclear. It is, however, important to note that expression
of Nmnat2-Venus in these mice does not commence until the post-
natal period, masking any potential effects of a stabilised Nmnat2 on
developmental processes. Additionally, rapid removal of Nmnat2
after an injury will of course facilitate rapid de- and re-generation
of axons, allowing quick functional recovery, which remains to be
tested in our Nmnat2Dex6-Venus mice.
In summary, our results support a role for the central ISTID region
in tuning Nmnat2 localisation, stability and protective capacity in
vivo. Loss of the central ISTID region transforms Nmnat2 from an
unstable, vesicle-associated protein that is nevertheless critical for
preventing spontaneous degeneration of unharmed axons, into a
widely distributed, stabilised protein that can robustly protect axons
after injury. Understanding the mechanisms behind this phenom-
enon could uncover novel avenues for axon protection through
modulation of endogenous Nmnat2.
Methods
Mouse strains. All animal work was carried out in accordance with the Animals
(Scientific Procedures) Act, 1986, under Project License 80/2254. C57BL/6JBabrmice
(BSU, Babraham Institute) were used for breeding. YFP-H mice (exact strain name:
B6.Cg-TgN(Thy1-YFP-H)2Jrs) used as controls were heterozygotes.
Generation of transgenic mice. Transgene expression in Nmnat2-Venus and
Nmnat2Dex6-Venus was driven by the Thy1.2-promoter that has previously been
described for the generation of neuron-specific transgenic mouse lines18–20. The
coding sequences of full-length mus musculus Nmnat2 or the Nmnat2Dex6 deletion
mutant9 were C-terminally fused to YFP Venus27 (kindly provided by Dr. Llewelyn
Roderick, Babraham Institute) and inserted into the Thy1.2 expression vector (a kind
gift from Prof. Thomas Misgeld, TU Munich). Transgenic mice were generated by
pronuclear injection (Babraham Institute Gene Targeting Facility) into C57BL6/CBA
Figure 5 | Nmnat2 deletion mutants with strongly increased protective capacity in Drosophila axons. (a) Representative images of GFP-positive
(OR22a1) axons in antennal lobes of flies expressing wild-type or mutant human Nmnat2 (wt – full-length Nmnat2, D32 – Nmnat2D32, D43 –
Nmnat2D43, D69 – Nmnat2D69, D82 – Nmnat2D82). Images were taken 7, 14 and 30 days after bilateral antennal ablation as indicated. (b)
Quantification of number of intact GFP-expressing axons in antennal lobe of flies expressing wild-type or mutant Nmnat2 isoforms scored 7, 14 and 30
days post-ablation. Age-matched untreated flies were used as controls. Error bars indicate SEM. n $ 3 antennal lobes per genotype and time point.
www.nature.com/scientificreports
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F1 zygotes. ForNmnat2-Venusmice, nine potential founders were identified and four
transgenic lines (1, 2, 3 and 8) were maintained as heterozygotes by crossing to
C57BL/6JBabr. Lines 1, 2 and 3 were used for experiments described in this study. For
Nmnat2Dex6-Venus, a single founder was identified and one transgenic line was
established, maintained by crossing to C57BL/6JBabr and used for this study.
PCR genotyping. PCR primers were designed to amplify a region of Nmnat2 from
the start of exon 9 to the end of exon 10 (fwd: 59-atggaagtgattgttggggac-39; rev: 59-
ctgctcttggtggagctgac-39). This resulted in a 300 bp fragment for endogenous Nmnat2
and a 170 bp fragment indicating the presence of Nmnat2-Venus or Nmnat2Dex6-
Venus as these constructs lack the intervening intron.
Collection of brains and nerves for western blot analysis. Brain and sciatic nerves
were dissected rapidly from freshly killed mice and frozen immediately by immersion
in liquid nitrogen. For lysis, tissue was allowed to thaw on ice and 500 ml (for brain
halves) or 50 ml (for sciatic nerve) TG lysis buffer was added (20 mM Tris pH 7.5,
137 mMNaCl, 1 mMEGTA, 1%TritonX-100, 10% glycerol, 1.5 mMMgCl2, 50 mM
NaF, 1 mMNa3VO4 and protease inhibitor mix). Tissue was disrupted by sonication
for 3 times 6 seconds on ice. Unbroken cells were removed by spinning samples at 13
000 rpm for 10 minutes at 4uC and transferring the supernatant to a new tube. Sciatic
nerve samples were diluted 151 and brain samples 154 into 23 SDS sample buffer
prior to SDS PAGE and Western Blot analysis.
Western blotting. SDS-PAGE analysis and Western Blotting analysis were
performed as described1,28. Anti-GFP antibody (Abcam ab290) was used at 152000,
anti-bIII-Tubulin (TUJ1, Covance) was used at 1515 000 and HRP-conjugated anti-
mouse and anti-rabbit IgG (BioRad) were used at 152000.
Tissue cryo-sectioning and staining. Nerves from freshly killed animals were
dissected rapidly and fixed by immersion into cold 4% PFA for at least 3 days, washed
3 times in 0.1 M PBS and cryopreserved in 30% sucrose supplemented with 0.1%
sodium azide for at least 3 days at 4uC. Tissue was sectioned on a Leica CM1850
cryostat. Typical section thickness was 20 mm for nerve cross-sections. Sections were
transferred onto Superfrost plus slides (VWR), allowed to dry and permeabilised in
PBS with 0.2% Triton-X 100 for 30 minutes at room temperature. Where indicated,
sections where then stainedwith FluoroMyelin Red stain according tomanufacturer’s
instructions (Life Technologies). Stained sections were imaged on an Olympus
FV1000 point scanning confocal microscope (IX81 microscope, 60 3 1.35 NA plan
super apochromat and 403 plan fluorite 1.3 NA objectives). For quantification of the
percentage of axons expressing the transgene, the total number of axons in a field was
determined by counting FluoroMyelin – stained myelin rings. Axons were scored as
positive for transgene expression if above-background levels of YFP fluorescence
were detectable in the axoplasm (see Figure 1a for examples of axons scored as
positive and negative for transgene expression). Six representative fields of view, each
of which contained about 100 axons, were counted and averaged per animal for a total
of n 5 4 animals per line.
Nerve whole-mount. For longitudinal sciatic nerve whole-mount preparations,
freshly dissected sciatic nerves were gently stretched during fixation using insect pins.
Nerves were fixed in 4% PFA for at least 2 days at 4uC. Fixed nerves were then washed
three times in 0.1 M PBS, transferred to a slide and a coverslip was mounted using
Vectashield (Vector Laboratories).
Semi-thin sectioning and staining. Sciatic nerves were fixed, embedded and
sectioned to 500 nm thickness as previously described29 and stained using
Richardson’s stain (0.5%Methylene Blue, 0.5% Azure II in 0.5% sodium tetraborate).
Stained sections were visualised on a brightfield microscope equipped with a colour
camera (Olympus BX41/Micropublisher 3.3 system, 100 3 1.4 NA objective).
Axonal transport imaging of sciatic nerve explants. Imaging of axonal transport in
sciatic nerve explants of Nmnat2-Venus and Nmnat2Dex6-Venus mice was
performed on an Olympus CellR imaging system (IX81 microscope, Hamamatsu
ORCA ER camera, 100 3 1.45 NA apochromat objective). During imaging, nerves
were maintained in oxygenated Neurobasal-A medium at 37uC in an environment
chamber (Solent Scientific). Images were captured at 2 frames per second. Following
imaging, individual axonswere straightened and kymographs generated using ImageJ
software plugins (Rasband, W.S., ImageJ, NIH, Bethesda, Maryland, USA, http://
imagej.nih.gov/ij/, 1997–2013).
Construction of Nmnat2 vectors and transgenic flies. Nmnat2 deletion mutants
(D32, D43, D69, and D82)21 were a gift from Prof. Giulio Magni (Ancona, Italy). The
ORF of human Nmnat2 (wild-type or deletion mutant) was amplified using the
oligonucleotides 59-AGTCAAGATCTACCCCACTGACCGAGACCACCAAG-
ACC-39 (59 primer with Kozak sequence and 59 BglII site) and 59-GGATCTCG-
AGCTAGCCGGAGGCATTGATGTACAGC-39 (39 primer with XhoI site), cloned
into a modified pJFRC-MUH plasmid (Addgene plasmid 26213; modified by cutting
pJFRC-MUHwith SbfI and SphI, removing 128 bp, including one 53UAS site), and
confirmed by DNA sequencing. Drosophila embryo injections were performed as a
fee-for-service (BestGene, Inc., Chino Hills, CA) and transgenic lines established in
the attP40 strain (estimated cytosite 25C7) were confirmed for the presence of the
wild-type or mutant transgene by sequencing of PCR product.
Antennal injury and axon quantification. OR22a-Gal422 and pUAST-mCD8::GFP
were combined with each Nmnat2 construct. We induced antennal injury using a
modification of a previously described protocol23. Newly eclosed adult flies were aged
for 7 days at 25uC before ablating both third antennal segments (bilateral injury).
Injured flies were aged at 25uC for the indicated time (7, 14, or 30 days) before
dissecting and fixing the brain. Axonal integrity was scored by counting the number
of intact GFP positive axons present.
Drosophila confocal microscopy. Samples were mounted in Vectashield antifade
reagent and viewed on a III Everest Spinning disk confocal microscope (403, 1.3 NA,
Plan Apochromat objective). The entire antennal lobe was imaged in 0.27 mm steps
for each sample for scoring axonal integrity.
Statistical analysis. Data presentation and statistical analysis were performed with
Prism 5 (GraphPad) and SPSS Statistics 20 (IBM) software.
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